Cyteir Therapeutics, Inc.
CYTDelisted Mar 18, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001662244
Cyteir Therapeutics, Inc. was delisted on Mar 18, 2024; its insiders filed their last Form 4 on Mar 25, 2024; 38 institutions reported holding it in 13F filings for Q4 2023, worth $38.9M in total; no superinvestor held it.
13F holders, Q3 2021
Institutional positions in Cyteir Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- +5 vs. Q2 2021
- Shares held
- 19.7M
- +3.07M (+18.5%) vs. Q2 2021
- Total value
- $344.1M
- −$8.51M (−2.4%) vs. Q2 2021
- New holders
- 19
- 11 more added
- Sold out
- 14
- 6 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CYT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 4 | $11.2M |
| Q4 2023 | 38 | $38.9M |
| Q3 2023 | 41 | $46.3M |
| Q2 2023 | 39 | $41.7M |
| Q1 2023 | 32 | $23.9M |
| Q4 2022 | 30 | $28.5M |
| Q3 2022 | 37 | $34.6M |
| Q2 2022 | 45 | $56.8M |
| Q1 2022 | 52 | $83.8M |
| Q4 2021 | 48 | $253.4M |
| Q3 2021 | 38 | $344.1M |
| Q2 2021 | 33 | $352.6M |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Cyteir Therapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 43 | $1.00K | 0.00% | +43 | New |
| State of Wyoming | 46 | $1.00K | 0.00% | +46 | New |
| UBS Group AG | 419 | $7.00K | 0.00% | −31−6.9% | Reduced |
| Tower Research Capital LLC (TRC) | 397 | $7.00K | 0.00% | +397 | New |
| Ameritas Investment Partners, Inc. | 641 | $11.0K | 0.00% | +641 | New |
| Legal & General Group Plc | 782 | $14.0K | 0.00% | +782 | New |
| Royal Bank of Canada | 1,179 | $20.0K | 0.00% | +884+299.7% | Added |
| Citigroup Inc | 1,222 | $21.0K | 0.00% | +1,222 | New |
| STRS Ohio | 1,900 | $33.0K | 0.00% | +1,900 | New |
| Morgan Stanley | 3,189 | $56.0K | 0.00% | +3,119+4,455.7% | Added |
| Steward Partners Investment Advisory, LLC | 3,375 | $59.0K | 0.00% | +3,375 | New |
| JPMorgan Chase & Co | 4,418 | $77.0K | 0.00% | +4,418 | New |
| California State Teachers Retirement System | 4,518 | $79.0K | 0.00% | +4,518 | New |
| American International Group, Inc. | 4,576 | $80.0K | 0.00% | +4,576 | New |
| Deutsche Bank AG | 4,812 | $84.0K | 0.00% | +4,812 | New |
| Nuveen Asset Management, LLC | 10,992 | $193.0K | 0.00% | +10,992 | New |
| Bank of America Corp | 12,328 | $216.0K | 0.00% | +12,318+123,180.0% | Added |
| Ghisallo Capital Management LLC | 15,000 | $263.0K | 0.01% | −10,000−40.0% | Reduced |
| ACT Capital Management, LLC | 15,000 | $263.0K | 0.14% | +14,910+16,566.7% | Added |
| Bank of New York Mellon Corp | 15,651 | $275.0K | 0.00% | +15,651 | New |
| Charles Schwab Investment Management Inc | 20,569 | $361.0K | 0.00% | +20,569 | New |
| Citadel Advisors LLC | 27,510 | $482.0K | 0.00% | +27,510 | New |
| Northern Trust Corp | 73,183 | $1.28M | 0.00% | +73,183 | New |
| State Street Corp | 91,891 | $1.61M | 0.00% | +91,891 | New |
| Geode Capital Management, LLC | 94,879 | $1.67M | 0.00% | +78,599+482.8% | Added |
| Sphera Funds Management Ltd. | 135,145 | $2.37M | 0.23% | +10,145+8.1% | Added |
| Sofinnova Investments, Inc. | 246,321 | $4.32M | 0.28% | −18,679−7.0% | Reduced |
| Ally Bridge Group (NY) LLC | 319,538 | $5.61M | 1.84% | −307,305−49.0% | Reduced |
| Vanguard Group Inc | 341,251 | $5.99M | 0.00% | +271,251+387.5% | Added |
| BlackRock Inc. | 391,399 | $6.87M | 0.00% | +391,399 | New |
| Acuta Capital Partners, LLC | 391,974 | $6.88M | 2.45% | +114,197+41.1% | Added |
| Caas Capital Management LP | 579,746 | $10.2M | 0.76% | +79,746+15.9% | Added |
| Baker Bros. Advisors LP | 812,640 | $14.3M | 0.06% | 00.0% | Unchanged |
| Avidity Partners Management LP | 1,683,441 | $29.5M | 0.75% | −124,953−6.9% | Reduced |
| Janus Henderson Group PLC | 1,878,224 | $31.9M | 0.01% | −11,609−0.6% | Reduced |
| Ra Capital Management, L.P. | 3,350,506 | $58.8M | 0.81% | +103,389+3.2% | Added |
| FMR LLC | 4,285,659 | $75.2M | 0.01% | +3,225,453+304.2% | Added |
| Novo Holdings A/S | 4,840,413 | $84.9M | 4.39% | 00.0% | Unchanged |
| Suvretta Capital Management, LLC | 0 | $0 | 0.00% | −175,000−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −145,000−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −138,165−100.0% | Sold out |
| HealthCor Management, L.P. | 0 | $0 | 0.00% | −120,000−100.0% | Sold out |
| Alliancebernstein L.P. | 0 | $0 | 0.00% | −110,000−100.0% | Sold out |
| Norges Bank | 0 | $0 | 0.00% | −110,000−100.0% | Sold out |
| Marshall Wace North America L.P. | 0 | $0 | 0.00% | −90,258−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −62,069−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −36,999−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −16,168−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −11,385−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −10,870−100.0% | Sold out |
| Pinz Capital Management, LP | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| AlphaCentric Advisors LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |